Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length
- PMID: 26701797
- PMCID: PMC4870839
- DOI: 10.3945/jn.115.222117
Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length
Abstract
Background: Not much is known about the relations of circulating saturated fatty acids (SFAs), which are influenced by both metabolic and dietary determinants, with total and cause-specific mortality.
Objective: We examined the associations of plasma phospholipid SFAs with total and cause-specific mortality among 3941 older adults from the Cardiovascular Health Study, a population-based prospective study of adults aged ≥65 y who were followed from 1992 through 2011.
Methods: The relations of total and cause-specific mortality with plasma phospholipid palmitic acid (16:0), stearic acid (18:0), arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0) were assessed using Cox proportional hazards models.
Results: During 45,450 person-years of follow-up, 3134 deaths occurred. Higher concentrations of the plasma phospholipid SFAs 18:0, 22:0, and 24:0 were associated with a lower risk of total mortality [multivariable-adjusted HRs (95% CIs)] for the top compared with the bottom quintile: 0.85 (0.75, 0.95) for 18:0; 0.85 (0.75, 0.95) for 22:0; and 0.80 (0.71, 0.90) for 24:0. In contrast, plasma 16:0 concentrations in the highest quintile were associated with a higher risk of total mortality compared with concentrations in the lowest quintile [1.25 (1.11, 1.41)]. We also found no association of plasma phospholipid 20:0 with total mortality.
Conclusions: These findings suggest that the associations of plasma phospholipid SFAs with the risk of death differ according to SFA chain length and support future studies to better characterize the determinants of circulating SFAs and to explore the mechanisms underlying these relations.
Keywords: SFAs; elderly; mortality; plasma phospholipid FAs; saturated fat.
© 2016 American Society for Nutrition.
Conflict of interest statement
Author disclosures: AM Fretts, DS Siscovick, IB King, B McKnight, BM Psaty, EB Rimm, C Sitlani, FM Sacks, X Song, N Sottodehnia, D Spiegelman, and RN Lemaitre, no conflicts of interest. D Mozaffarian reports ad hoc honoraria from Bunge, Pollock Institute, and Quaker Oats; ad hoc consulting for Foodminds, Nutrition Impact, Amarin, Astra Zeneca, Winston and Strawn LLP, and Life Sciences Research Organization; membership, Unilever North America Scientific Advisory Board; and chapter royalties from UpToDate.
References
-
- Iggman D, Riserus U. Role of different dietary saturated fatty acids for cardiometabolic risk. Clin Lipidol 2011;6:209–23.
-
- Grösch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res 2012;51:50–62. - PubMed
-
- Schwab US, Maliranta HM, Sarkkinen ES, Savolainen MJ, Kesaniemi YA, Uusitupa MI. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism 1996;45:143–9. - PubMed
-
- Connor WE. Harbingers of coronary heart disease: dietary saturated fatty acids and cholesterol. Is chocolate benign because of its stearic acid content? Am J Clin Nutr 1999;70:951–2. - PubMed
-
- Wakil SJ. Fatty-acid synthase, a proficient multifunctional enzyme. Biochemistry 1989;28:4523–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01HC55222/HC/NHLBI NIH HHS/United States
- N01HC85080/HC/NHLBI NIH HHS/United States
- R01 HL085710/HL/NHLBI NIH HHS/United States
- R01-HL085710/HL/NHLBI NIH HHS/United States
- T32HL007902/HL/NHLBI NIH HHS/United States
- 5KL2TR000421/TR/NCATS NIH HHS/United States
- N01HC85081/HC/NHLBI NIH HHS/United States
- N01HC85079/HC/NHLBI NIH HHS/United States
- N01HC85086/HC/NHLBI NIH HHS/United States
- R01AG023629/AG/NIA NIH HHS/United States
- N01HC85082/HC/NHLBI NIH HHS/United States
- HHSN268200800007C/PHS HHS/United States
- KL2 TR002317/TR/NCATS NIH HHS/United States
- HHSN268201200036C/PHS HHS/United States
- KL2 TR000421/TR/NCATS NIH HHS/United States
- N01HC85083/HC/NHLBI NIH HHS/United States
- U01HL080295/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
